Sorin completes first U.S. implant of aortic pericardial heart valve

The Sorin Group, a medical technologies company for cardiac surgery, has completed the first commercial U.S. implant of its Mitroflow aortic pericardial heart valve, performed by the Cardiovascular Surgery Division at Mayo Clinic in Rochester, Minn.

The Milano, Italy-based Sorin said its Mitroflow valve, introduced in Europe in 1982, has the pericardium mounted on the outside of the stent, allowing for valve opening and blood flow.

The Mitroflow valve received FDA approval in October and is now available to cardiac surgeons and their patients in the United States. 

Around the web

Richard Heller III, MD, RSNA board member and senior VP of policy at Radiology Partners, offers an overview of policies in Congress that are directly impacting imaging.
 

The two companies aim to improve patient access to high-quality MRI scans by combining their artificial intelligence capabilities.

Positron, a New York-based nuclear imaging company, will now provide Upbeat Cardiology Solutions with advanced PET/CT systems and services.